Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...
GE Vernova (NYSE:GEV) +2.9% in early trading Wednesday, rising to an all-time high $434.10 and potentially heading for a ...
The streamer’s in-house offerings will hit the U.S. in April, coinciding with an upfronts market where publishers lock in ...
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.